BTA 0.00% 57.0¢ biota holdings limited

Ann: Phase III prophylaxis trial for CS-8958 , page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,630 Posts.
    lightbulb Created with Sketch. 4
    Jessie, Interesting document.

    Inclusion Criteria = "Subjects judged as negative for influenza virus infection using a specified diagnostic kit"

    Candidates in trial were pre-exposed to infection - but before development of symptoms (blood temp checked) or judged as negative to infection with above kit. I presume kit meassures antibodies to influenza.

    What if the diagnostic kit is fallible? ie - candidate has had sufficient exposure for influenza development but cannot be detected at outset of trial?

    If 50% of candidates in this category and other 50% were prevented then we have an exceptionally good result.

    Is this possible??
 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.